Pseudotumor cerebri in two adolescents with acquired aplastic anemia

被引:15
作者
Jeng, MR
Rieman, M
Bhakta, M
Helton, K
Wang, WC
机构
[1] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Diagnost Imaging, Memphis, TN 38105 USA
[3] Univ Tennessee, Dept Pediat, Memphis, TN USA
[4] St Jude Childrens Res Hosp Domest Affiliate, Dept Hematol Oncol, Chattanooga, TN USA
关键词
aplastic anemia; intracranial pressure; papilledema; cerebrospinal fluid; pseudotumor cerebri; headache; acetazolamide; carbonic anhydrase inhibitors;
D O I
10.1097/00043426-200212000-00018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 13-year-old boy and a 16-year-old girl both presented with headaches and nausea after they were diagnosed with severe acquired aplastic anemia. Both patients had symptoms and signs consistent with the clinical syndrome of pseudotumor cerebri including headaches, nausea, papilledema, and elevated intracranial pressure. Both patients were treated with therapeutic lumbar puncture and acetazolamide, which relieved their symptoms. Acetazolamide dosage was given while the patients underwent an immunosuppressive regimen. We hypothesize that the pseudotumor cerebri in these two pediatric patients was the result of an increased production of cerebrospinal fluid in response to anemia and that the removal of fluid and treatment with acetazolamide appear to be helpful in such cases.
引用
收藏
页码:765 / 768
页数:4
相关论文
共 20 条
[1]  
AKTAN S, 1984, J CLIN NEURO-OPHTHAL, V4, P47
[2]  
ALTER BP, 1993, HEMATOLOGY INFANCY C, P216
[3]  
Brodsky MC, 1997, AM J NEURORADIOL, V18, P1592
[4]  
CAPRILES L, 1963, ARCH NEUROL-CHICAGO, V168, P147
[5]  
FERRI FF, 1991, PRACTICAL GUIDE CARE, P588
[6]  
*GEN I INC, 2000, NEUMEGA OPR
[7]   TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD PRESENTING WITH PAPILLEDEMA [J].
GREEN, NS ;
GARVIN, JH ;
CHUTORIAN, A .
CLINICAL PEDIATRICS, 1986, 25 (05) :278-279
[8]  
HASLAM R, 1996, TXB PEDIAT, P1669
[9]  
HAYE C, 1974, ARCH OPHTALMOL-PARIS, V34, P793
[10]  
ISLES AF, 1993, PEDIAT PHARM THERAPE, P243